BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15505629)

  • 1. Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer.
    Benoy IH; Elst H; Van der Auwera I; Van Laere S; van Dam P; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Br J Cancer; 2004 Nov; 91(10):1813-20. PubMed ID: 15505629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
    Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
    Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer.
    Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
    Br J Cancer; 2006 Mar; 94(5):672-80. PubMed ID: 16495933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19.
    Grünewald K; Haun M; Urbanek M; Fiegl M; Müller-Holzner E; Gunsilius E; Dünser M; Marth C; Gastl G
    Lab Invest; 2000 Jul; 80(7):1071-7. PubMed ID: 10908152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow.
    Tjensvoll K; Gilje B; Oltedal S; Shammas VF; Kvaløy JT; Heikkilä R; Nordgård O
    Breast Cancer Res Treat; 2009 Jul; 116(2):329-38. PubMed ID: 18846421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
    Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
    Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA.
    Zach O; Kasparu H; Krieger O; Hehenwarter W; Girschikofsky M; Lutz D
    J Clin Oncol; 1999 Jul; 17(7):2015-9. PubMed ID: 10561252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer.
    Ooka M; Tamaki Y; Sakita I; Fujiwara Y; Yamamoto H; Miyake Y; Sekimoto M; Ohue M; Sugita Y; Miyoshi Y; Ikeda N; Noguchi S; Monden M
    Breast Cancer Res Treat; 2001 May; 67(2):169-75. PubMed ID: 11519865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
    Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
    Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of RT-PCR detection of human mammaglobin for the diagnosis of breast cancer derived pleural effusions.
    Roncella S; Ferro P; Bacigalupo B; Dessanti P; Pronzato P; Franceschini MC; Pratticò L; Carletti AM; Canessa PA; Fontana V; Fais F; Pistillo MP; Fedeli F
    Diagn Mol Pathol; 2008 Mar; 17(1):28-33. PubMed ID: 18303409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study.
    Valladares-Ayerbes M; Iglesias-Díaz P; Díaz-Prado S; Ayude D; Medina V; Haz M; Reboredo M; Antolín S; Calvo L; Antón-Aparicio LM
    J Cancer Res Clin Oncol; 2009 Sep; 135(9):1185-95. PubMed ID: 19221791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
    Chen Y; Zou TN; Wu ZP; Zhou YC; Gu YL; Liu X; Jin CG; Wang XC
    Int J Biol Markers; 2010; 25(2):59-68. PubMed ID: 20586026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.
    Slade MJ; Smith BM; Sinnett HD; Cross NC; Coombes RC
    J Clin Oncol; 1999 Mar; 17(3):870-9. PubMed ID: 10071278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
    Zippelius A; Kufer P; Honold G; Köllermann MW; Oberneder R; Schlimok G; Riethmüller G; Pantel K
    J Clin Oncol; 1997 Jul; 15(7):2701-8. PubMed ID: 9215843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new comprehensive gene expression panel to study tumor micrometastasis in patients with high-risk breast cancer.
    Ferrucci PF; Rabascio C; Gigli F; Corsini C; Giordano G; Bertolini F; Martinelli G
    Int J Oncol; 2007 Apr; 30(4):955-62. PubMed ID: 17332935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients.
    Gilje B; Nordgård O; Tjensvoll K; Borgen E; Synnestvedt M; Smaaland R; Naume B
    BMC Cancer; 2014 Jul; 14():514. PubMed ID: 25023626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer.
    Janku F; Kleibl Z; Novotny J; Tesarova P; Petruzelka L; Matous B
    Neoplasma; 2004; 51(3):204-8. PubMed ID: 15254674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients.
    Jung YS; Lee KJ; Kim HJ; Yim HE; Park JS; Soh EY; Kim MW; Park HB
    Jpn J Clin Oncol; 2003 Apr; 33(4):167-72. PubMed ID: 12810830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.
    Schoenfeld A; Kruger KH; Gomm J; Sinnett HD; Gazet JC; Sacks N; Bender HG; Luqmani Y; Coombes RC
    Eur J Cancer; 1997 May; 33(6):854-61. PubMed ID: 9291805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.